SOC di Nefrologia, PO A Landolfi, ASL AVELLINO, Solofra, AV, Italy.
Nephrol Dial Transplant. 2010 May;25(5):1579-83. doi: 10.1093/ndt/gfp662. Epub 2009 Dec 22.
The major determinants of pulse wave velocity (PWV) in haemodialysis (HD) patients are not fully known. We studied chronic HD patients to assess the effect of cyclic variations in both hydration status and blood pressure on PWV.
Twenty patients were examined along three consecutive HD sessions and interdialysis periods during a week-long period. Twenty healthy subjects and 20 chronic kidney disease (CKD) patients (stage 5) were evaluated as controls.
In contrast to controls, HD patients showed cyclic changes in PWV. Specifically, PWV values in HD patients were significantly higher prior to the first HD session of the week compared with values measured prior to the other two HD sessions during the week. In addition, PWV showed significant reductions during each dialysis session (15.6 +/- 5.2 to 9.3 +/- 2.3, 13.4 +/- 4.0 to 8.7 +/- 2.4, and 12.4 +/- 2.6 to 9.2 +/- 2.2 m/sec, before and after the first, second and third weekly dialysis sessions, respectively). Nevertheless, the weighted weekly values of PWV in HD patients (10.8 +/- 5.7 m/sec) were similar to those in CKD patients (9.9 +/- 4.2 m/sec). The HD ultrafiltration rate (UF) was significantly correlated with intradialysis PWV changes (r = 0.465; P < 0.001) and with after dialysis PWV values (r = -0.654; P < 0.0001). Blood pressure changes during dialysis were weakly correlated with post-dialysis PWV (r = -0.267; P < 0.05), but not with PWV changes during dialysis.
In chronic HD patients, single PWV values varied widely during 1 week of HD sessions, whereas the weighted level showed only a slight increase. The major determinant of changes in PWV during HD appears to be the alterations in hydration status; the most representative time point for PWV measurements during HD corresponds to the interdialysis days.
血液透析(HD)患者脉搏波速度(PWV)的主要决定因素尚不完全清楚。我们研究了慢性 HD 患者,以评估水合状态和血压的周期性变化对 PWV 的影响。
在一周的时间内,连续检查了 20 名患者在三次 HD 治疗期间和透析间隔期间的情况。20 名健康受试者和 20 名慢性肾脏病(CKD)患者(第 5 阶段)作为对照组进行了评估。
与对照组相比,HD 患者的 PWV 呈周期性变化。具体来说,HD 患者在本周第一次 HD 治疗前的 PWV 值明显高于本周另外两次 HD 治疗前的 PWV 值。此外,在每次透析过程中 PWV 均显著降低(15.6±5.2 至 9.3±2.3、13.4±4.0 至 8.7±2.4、12.4±2.6 至 9.2±2.2 m/s,分别为每周第一次、第二次和第三次透析前后)。然而,HD 患者的 PWV 每周加权值(10.8±5.7 m/s)与 CKD 患者相似(9.9±4.2 m/s)。HD 超滤率(UF)与透析期间 PWV 变化(r=0.465;P<0.001)和透析后 PWV 值(r=-0.654;P<0.0001)显著相关。透析期间血压变化与透析后 PWV 呈弱相关(r=-0.267;P<0.05),但与透析期间 PWV 变化无关。
在慢性 HD 患者中,单次 PWV 值在一周的 HD 治疗期间变化很大,而加权水平仅略有增加。HD 期间 PWV 变化的主要决定因素似乎是水合状态的改变;HD 期间 PWV 测量的代表性时间点对应于透析间隔日。